Introduction |
|
|
The Kidney in Plasma Cell Dyscrasias: A Current View and a Look at the Future |
|
|
1 | (4) |
|
Herrear, G.A. (Saint Louis, Mo.) |
|
|
|
A History of the Kidney in Plasma Cell Disorders |
|
|
5 | (20) |
|
Steensma, D.P.; Kyle, R.A. (Rochester, Minn.) |
|
|
|
Pathologic Studies Useful for the Diagnosis and Monitoring of Plasma Cell Dyscrasias |
|
|
25 | (19) |
|
Veillon, D.M.; Cotelingam, J.D. (Shreveport, La.) |
|
|
|
Serum Free Light Chains in the Diagnosis and Monitoring of Patients with Plasma Cell Dyscrasias |
|
|
44 | (22) |
|
Mayo, M.M.; Schaef Johns, G. (St. Louis, Mo.) |
|
|
|
Mechanisms of Renal Damage in Plasma Cell Dyscrasias: An Overview |
|
|
66 | (21) |
|
Merlini, G. (Pavia); Pozzi, C. (Lecco) |
|
|
|
Proximal Tubular Injury in Myeloma |
|
|
87 | (18) |
|
Batuman, V. (New Orleans, La.) |
|
|
|
Paraproteinemic Renal Diseases that Involve the Tubulo-Interstitium |
|
|
105 | (11) |
|
Herrera, G.A. (St. Louis, Mo.); Sanders, P.W. (Birmingham, Ala.) |
|
|
|
The Mesangium as a Target for Glomerulopathic Light and Heavy Chains: Pathogenic Considerations in Light and Heavy Chain-Mediated Glomerular Damage |
|
|
116 | (19) |
|
Keeling, J.; Herrera, G.A. (St. Louis, Mo.) |
|
|
|
Immunoglobulin Light and Heavy Chain Amyloidosis AL/AH: Renal Pathology and Differential Diagnosis |
|
|
135 | (21) |
|
Picken, M.M. (Maywood, III.) |
|
|
|
Diversity and Diversification of Light Chains in Myeloma: The Specter of Amyloidogenesis by Proxy |
|
|
156 | (26) |
|
Gu, M.; Wilton, R.; Stevens, F.J. (Argonne, III.) |
|
|
|
High-Dose Therapy in Patients with Plasma Cell Dyscrasias and Renal Dysfunction |
|
|
182 | (13) |
|
Pineda-Roman, M.; Tricot, G. (Little Rock, Ark.) |
|
|
|
Current and Emerging Views and Treatments of Systemic Immunoglobulin Light-Chain (AL) Amyloidosis |
|
|
195 | (16) |
|
Comenzo, R.L. (New York, N.Y.) |
|
|
Author Index |
|
211 | (1) |
Subject Index |
|
212 | |